Dr. Daniel Jacob Cwikla, MD

Dr. Cwikla practices at UCI Health - Orange in Orange, California, part of UC Irvine.

Dr. Cwikla's NPI, 1205278603, was assigned on July 25, 2013. Dr. Cwikla graduated from Joe R. & Teresa Lozano Long School of Medicine in 2013. Dr. Cwikla holds California license A137376.

Dr. Cwikla's primary practice is UCI Health - Orange, at 101 City Drive South, Orange, CA 92868 in Orange County. The practice phone is (714) 456-7890.

Dr. Cwikla's primary practice is UCI Health - Orange in Orange, California, part of UC Irvine. Dr. Cwikla is also affiliated with Hoag Hospital Newport Beach. The medical group on file is UCI Health Center for Urological Care.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cwikla practices, 2 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Cwikla's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Cwikla is board certified in urology by the American Board of Urology. Dr. Cwikla is licensed in California.

Dmand AI lists bladder disease, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney disease, kidney removal surgery, kidney stone disease and prostate cancer among the conditions Dr. Cwikla treats.

CMS data shows 800 Medicare services from Dr. Cwikla across 11 procedure codes in 2024, for 442 Medicare patients. Medicare paid $65,024 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 442 Medicare patients who saw Dr. Cwikla in 2024. The largest group is 65 to 74, with 209 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 49% are also on Medicaid. Their average risk score is 2.32, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Cwikla's median patient age at 65, with 20% women.

In 2024, Dr. Cwikla wrote 1,555 Medicare Part D claims for 370 patients. 90% of them were for generic drugs. CMS names the drug for 1,406 of them, across 16 drugs with 11 or more claims each, at $127,650 in total drug cost. In 2023, CMS named 1,097 claims across 13 drugs.

Dr. Cwikla accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Cwikla as offering telehealth. CMS counts 31 procedures of prostate resection by Dr. Cwikla, more than 92% of the clinicians it reports for that procedure.

Dmand AI links 3 papers to Dr. Cwikla, published from 2016 to 2018. Dr. Cwikla's most frequent co-authors are Ralph V. Clayman, MD and Kamaljot Singh Kaler, FRCSC, MD.

CMS Open Payments shows 10 general payments to Dr. Cwikla from 7 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 100% of the total. Calyxo, Inc. paid the most, $226.

Dr. Cwikla graduated from Joe R. & Teresa Lozano Long School of Medicine in 2013.

Dr. Cwikla is in network with 17 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.